Skip to Main Content

Author Details

Bryan M McCauley
Division of Clinical Trials and Biostatistics, Mayo Clinic
2016
26
11
PMIDPaper TitleJournal TitlePublished Year
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37076803Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.BMC Gastroenterol2023
33939140Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.Dig Dis Sci2022
35473391DNA methylation profile of liver tissue in end-stage cholestatic liver disease.Epigenomics2022
36456881The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.Nat Genet2022
35931468Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.Gynecol Oncol2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
33226645Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.Hepatology2021
34916903Plasma Cell-Free DNA Methylomics of Bipolar Disorder With and Without Rapid Cycling.Front Neurosci2021
34563121The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis.BMC Gastroenterol2021
33978301Environmental risk factors are associated with autoimmune hepatitis.Liver Int2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
29742811Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.Hepatology2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
30576442Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.Hum Mol Genet2019
31420334Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.Blood2019
29502561MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Mayo Clin Proc2018
30219500Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathy.J Neurol Sci2018
29881819External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.Hepatol Commun2018
29049607Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.JAMA Oncol2017
28245345Variations in primary sclerosing cholangitis across the age spectrum.J Gastroenterol Hepatol2017
28203683Identification of unique venous thromboembolism-susceptibility variants in African-Americans.Thromb Haemost2017
29036934Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.Int J Environ Res Public Health2017
29029385Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.Oncotarget2017
27062298Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.Liver Int2016
  • 1 - 26 of 26

Recommended Authors

Mayo Clinic
Career Start Year 2013
Number of shared co-authors 9
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 2011
Number of shared co-authors 5
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 11
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 3
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 5
The Ohio State University
Career Start Year 2007
Number of shared co-authors 75
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 1
University of Cambridge
Career Start Year 2006
Number of shared co-authors 4
Translational and Clinical Data Sciences
Career Start Year 2006
Number of shared co-authors 2
Duke University
Career Start Year 2005
Number of shared co-authors 5
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 62
Humanitas University
Career Start Year 2003
Number of shared co-authors 4
Queen's University
Career Start Year 2002
Number of shared co-authors 7
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Lee Kong Chian School of Medicine, Nanyang Technological University
Career Start Year 2001
Number of shared co-authors 7
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 21
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 84
University of California los angeles
Career Start Year 2001
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 2
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Career Start Year 1996
Number of shared co-authors 4
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 2
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 11
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 6
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 72

Collaborators

Mayo Clinic
Co-authored papers 12
Mayo Clinic College of Medicine
Co-authored papers 11
Mayo Clinic
Co-authored papers 10
Mayo Clinic
Co-authored papers 10
Mayo Clinic
Co-authored papers 8
Westmead Hospital
Co-authored papers 8
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 7
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 7
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 7
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 7
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 7
University of British Columbia
Co-authored papers 7
David Geffen School of Medicine, University of California los angeles
Co-authored papers 7
Instituto de Salud Carlos III
Co-authored papers 6
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 6
Peter MacCallum Cancer Centre
Co-authored papers 6
University of Calgary
Co-authored papers 6
Peter MacCallum Cancer Centre
Co-authored papers 6
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 6
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Otto-Friedrich-University Bamberg
Co-authored papers 6
Mayo Clinic
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 5
Co-authored papers 4
University of Cambridge
Co-authored papers 4
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 4
Co-authored papers 4
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 4
Co-authored papers 4